• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Frontier Bio’s Lab-Grown Lungs Offers Hope for Drug Development

by Fred Pennic 10/01/2024 Leave a Comment

Frontier Bio's Lab-Grown Lungs Offers Hope for Drug Development

What You Should Know:  - Frontier Bio Corporation has successfully created complex microscale lung tissue by combining 3D bioprinting with the self-assembling capabilities of stem cells, mirroring the natural organ development process.  - Frontier Bio's breakthrough in lab-grown lung tissue signifies a potential turning point in the fight against respiratory diseases and the quest for viable organ transplantation options. Addressing the Limitations of Animal Testing Animal
Read More

Medidata Launches Patient Payments: Streamlining Clinical Trial Reimbursements

by Syed Hamza Sohail 09/26/2024 Leave a Comment

Medidata Launches Patient Payments: Streamlining Clinical Trial Reimbursements

What You Should Know: - Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research. - This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses,
Read More

StudyTeam for Sites Reaches 10,000 Global Research Sites, Streamlining Clinical Trials

by Syed Hamza Sohail 09/24/2024 Leave a Comment

StudyTeam for Sites Reaches 10,000 Global Research Sites, Streamlining Clinical Trials

What You Should Know: - OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based software platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows online and enables sites, sponsors, and other key stakeholders to work together more effectively using common technology. -  The suite of StudyTeam solutions reduces site burden and helps sites pre-screen and enroll more patients, provides sponsors with
Read More

The Role of Stem Cell Therapy in the Future of Personalized Medicine

by Fred Pennic 09/23/2024 Leave a Comment

The Role of Stem Cell Therapy in the Future of Personalized Medicine

In the rapidly evolving landscape of healthcare, personalized medicine is making waves by offering tailored therapies that cater to the unique needs of individual patients. One of the most promising advancements in this field is stem cell therapy, particularly autologous stem cell therapy, which utilizes a patient's own cells to promote healing naturally. Unlike traditional treatments, stem cells have a unique ability to enhance the body’s natural healing process, offering a new dimension of
Read More

Medical Experts Utilize NVIDIA-Powered Federated Learning to Advance AI in Tumor Segmentation

by Fred Pennic 09/23/2024 Leave a Comment

Medical Experts Utilize NVIDIA-Powered Federated Learning to Advance AI in Tumor Segmentation

What You Should Know:  - A team of experts from leading U.S. medical centers and research institutions is utilizing NVIDIA-powered federated learning to investigate the impact of this technique and AI-assisted annotation in training AI models for tumor segmentation.  - NVIDIA-powered federated learning aims to overcome data-sharing challenges and accelerate the development of more accurate and generalizable AI models in medical imaging. Federated Learning: Revolutionizing Data
Read More

Verily Expands Wastewater Surveillance Testing to Europe

by Syed Hamza Sohail 09/18/2024 Leave a Comment

Verily Expands Wastewater Surveillance Testing to Europe

What You Should Know: - Verily, a precision health technology company, announced a significant expansion of its wastewater surveillance program into the United Kingdom through an exclusive partnership with Bangor University. -  This collaboration will leverage the university’s wastewater-based public health surveillance program capabilities and main testing lab. Bangor University’s wastewater monitoring capabilities are market leading in the U.K. for environmental bio-surveillance and the
Read More

GI Partners Makes Major Investment in eClinical Solutions

by Jasmine Pennic 09/13/2024 Leave a Comment

GI Partners Makes Major Investment in eClinical Solutions

What You Should Know:  - eClinical Solutions LLC, a provider of digital clinical software and services, announced that it has received a majority investment from GI Partners, a private investment firm.  - This investment highlights eClinical Solutions' strong position as a trusted partner for life science organizations of all sizes seeking to accelerate research and advance therapeutic breakthroughs in an increasingly complex trial landscape. GI Partners' Commitment to
Read More

Sheba Medical, Paradigm Health Partner to Optimize Clinical Trials

by Fred Pennic 09/12/2024 Leave a Comment

Sheba Hospital Develops Generative AI Platform to Improve Mental Healthcare Access

What You Should Know:  - Sheba Medical Center, Israel’s largest hospital, and ARC Innovation, the innovation arm of Sheba, has announced a strategic partnership with Paradigm Health to establish a global network for clinical research.  - This collaboration aims to revolutionize the way clinical trials are conducted, making them more accessible, efficient, and patient-centered. Leveraging AI to Optimize Clinical Trials The partnership will utilize Paradigm's AI-driven
Read More

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

by Fred Pennic 09/11/2024 Leave a Comment

Gilead Sciences and Genesis Therapeutics Partner on AI-Driven Drug Discovery

What You Should Know:  - Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.  - The startegic partnership leverages Genesis' cutting-edge AI platform, GEMS, to accelerate drug discovery and development. A Powerful Collaboration Genesis Therapeutics' GEMS platform utilizes advanced AI techniques to generate and
Read More

American Cancer Society and Yosemite Award $6M in Research Grants to Innovate Cancer Scientists

by Syed Hamza Sohail 09/10/2024 Leave a Comment

American Cancer Society and Yosemite Award $6M in Research Grants to Innovative Cancer Scientists

What You Should Know:  The American Cancer Society (ACS) and Yosemite, an oncology-focused venture capital firm, announced the selection of research grants through their Yosemite-ACS Award totaling more than $6 million.These inaugural grants will go to scientists from institutions across the country and are poised to make an impact in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 14
  • Go to page 15
  • Go to page 16
  • Go to page 17
  • Go to page 18
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |